🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Imatinib mesylate may stop the growth of tumor cells by blocking...
Status
Completed
Location
Duke Cancer Institute
Start Date
2005-05
Trial ID
NCT00354913
Treatments Being Tested
Chronic myeloid leukaemia (CML) is due to a chromosomal abnormality in whit...
Status
Unknown
Location
Auckland City Hospital
Start Date
2017-07-17
Trial ID
NCT03193281
The study was performed to assess: 1) clinical activity of Imatinib in pati...
Status
Completed
Location
USC Ematologia Ospedali Riuniti di Bergamo
Start Date
2004-10
Trial ID
NCT00787384
Treatments Being Tested
Evaluation of the efficacy and safety of withdrawal of tyrosine kinase inhi...
Status
Active Not Recruiting
Location
University Hospital Brno
Start Date
2020-06-16
Trial ID
NCT04147533
Treatments Being Tested
This will be an open label, multi-center study of up to 77 patients with CM...
Status
Terminated
Location
Univ. of Texas M.D. Anderson Cancer Center
Start Date
2005-10
Trial ID
NCT00114959
Treatments Being Tested
The trial "The stop-GIST trial" is an Oslo University Hospital sponsored, p...
Status
Suspended
Location
Oslo University Hospital
Start Date
2017-01
Trial ID
NCT02924714
Treatments Being Tested
This is a Phase 1, open-label, first-in-human (FIH) study designed to evalu...
Status
Completed
Location
Scottsdale Healthcare Hospitals DBA HonorHealth
Start Date
2015-08
Trial ID
NCT02508532
Treatments Being Tested
To assess the efficacy of inecalcitol in combination with imatinib in CML p...
Status
Unknown
Location
CHU Côte de Nacre
Start Date
2014-02
Trial ID
NCT02949570
Treatments Being Tested
REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform tria...
Status
Recruiting
Location
University of Florida
Start Date
2016-04-11
Trial ID
NCT02735707
Treatments Being Tested
The purpose of this study is to determine if adding Ruxolitinib to a Tyrone...
Status
Active Not Recruiting
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2019-11-19
Trial ID
NCT03610971
Treatments Being Tested